AgomAb Therapeutics NV (AGMB) vs Tectonic Therapeutic (TECX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Tectonic Therapeutic is the larger company by market cap ($444.0 million vs $433.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AGMB | TECX |
|---|---|---|
| Share price | $8.80 | $22.71 |
| Market cap | $433.38M | $443.97M |
| 1-day change | -0.45% | +1.34% |
| YTD return | — | +8.87% |
| 1-year return | — | +52.31% |
| 5-year return | — | -67.37% |
| EPS (TTM) | $-2.08 | $-4.57 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.82 | $39.53 |
| 52-week low | $7.97 | $14.81 |
| Distance from 52-week high | -50.62% | -42.55% |
| Average volume | 135.61K | 220.06K |
| Shares outstanding | 49.25M | 19.55M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
AGMB vs TECX FAQ
Which is bigger, AgomAb Therapeutics NV or Tectonic Therapeutic?
Tectonic Therapeutic (TECX) is larger, with a market capitalization of $443.97M compared with $433.38M for AgomAb Therapeutics NV (AGMB).
Are AgomAb Therapeutics NV and Tectonic Therapeutic in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.